Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: Bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma

American Journal of Surgical Pathology

Volumn 28, Issue 10, 2004, Pages 1280-1288

  Sasatomi, Eizaburo ^a,b   Johnson, Lawrence R ^a   Aldeeb, Dalal N ^a   Lomago, Deren M ^a   Thompson Jr , James W ^a   Swalsky, Patricia A ^a   Luketich, James D ^a   Fernando, Hiran C ^a   Finkelstein, Sydney D ^a   Yousem, Samuel A ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Adenocarcinoma; Bronchioloalveolar carcinoma; Loss of heterozygosity; Lung

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER INVASION; CANCER STAGING; CHROMOSOME 17P; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME MICRODISSECTION; FEMALE; GENE LOCUS; GENETIC HETEROGENEITY; HETEROZYGOSITY LOSS; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; MALE; MUTATION;

ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS;

EID: 5044241540     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000138001.69521.0e     Document Type: Article

References (37)

1. Aoyagi Y, Yokose T, Minami Y, et al. Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma. Cancer Res. 2001;61:7950-7954.
2. Arvanitis DA, Papadakis E, Zafiropoulos A, et al. Fractional allele loss is a valuable marker for human lung cancer detection in sputum. Lung Cancer. 2003;40:55-66.
3. Barsky SH, Grossman DA, Ho J, et al. The multifocality of bronchioloalveolar lung carcinoma: evidence and implications of a multiclonal origin. Mod Pathol. 1994;7:633-640.
4. Bruhn N, Beinert T, Oehm C, et al. Detection of microsatellite alterations in the DNA isolated from tumor cells and from plasma DNA of patients with lung cancer. Ann N Y Acad Sci. 2000;906:72-82.
5. Dacic S, Finkelstein SD, Sasatomi E, et al. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol. 2002;26:510-516.
6. Dreesen JC, Bras M, Coonen E, et al. Allelic dropout caused by allele-specific amplification failure in single-cell PCR of the cystic fibrosis delta F508 deletion. J Assist Reprod Genet. 1996;13:112-114.
7. Fidler IJ. Molecular Biology of Cancer: Invasion and metastasis. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. Philadelphia, PA: Lippincott-Raven, 1997:135-152.
8. Fong KM, Kida Y, Zimmerman PV, et al. MYCL genotypes and loss of heterozygosity in non-small-cell lung cancer. Br J Cancer. 1996;74: 1975-1978.
9. Goeze A, Schluns K, Wolf G, et al. Chromosomal imbalances of primary and metastatic lung adenocarcinomas. J Pathol. 2002;196:8-16.
10. Healy E, Belgaid C, Takata M, et al. Prognostic significance of allelic losses in primary melanoma. Oncogene. 1998;16:2213-2218.
11. Holst VA, Finkelstein S, Yousem SA. Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. Am J Surg Pathol. 1998;22:1343-1350.
12. Lichy JH, Dalbegue F, Zavar M, et al. Genetic heterogeneity in ductal carcinoma of the breast. Lab Invest. 2000;80:291-301.
13. Liloglou T, Maloney P, Xinarianos G, et al. Cancer-specific genomic instability in bronchial lavage: a molecular tool for lung cancer detection. Cancer Res. 2001;61:1624-1628.
14. Rusch VW, Appelman HD, Byhardt R, et al. Lung. In: Greene FL, Page DL, Fleming ID et al. eds. American Joint Committee on Cancer: AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag, 2002:167-177.
15. Mariatos G, Gorgoulis VG, Zacharatos P, et al. Expression of p16 (INK4A) and alterations of the 9p21-23 chromosome region in non-small-cell lung carcinomas: relationship with tumor growth parameters and ploidy status. Int J Cancer. 2000;89:133-141.
16. Mendoza C, Sato H, Hiyama K, et al. Allelotype and loss of heterozygosity around the L-myc gene locus in primary lung cancers. Lung Cancer. 2000;28:117-125.
17. Mertens F, Johansson B, Hoglund M, et al. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res. 1997;57:2765-2780.
18. Deleted in proof.
19. Nakayama S, Nakayama K, Takebayashi Y, et al. Allelotypes as potential prognostic markers in ovarian carcinoma treated with cisplatin-based chemotherapy. Int J Mol Med. 2003;11:621-625.
20. Nomoto S, Haruki N, Tatematsu Y, et al. Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer. 2000;28:342-346.
21. Nordenson I, Ljungberg B, Roos G. Chromosomes in renal carcinoma with reference to intratumor heterogeneity. Cancer Genet Cytogenet. 1988;32:35-41.
22. Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194:23-28.
23. Partridge M, Emilion G, Pateromichelakis S, et al. The prognostic significance of allelic imbalance at key chromosomal loci in oral cancer. Br J Cancer. 1999;79:1821-1827.
24. Petersen S, Wolf G, Bockmuhl U, et al. Allelic loss on chromosome 10q in human lung cancer: association with tumour progression and metastatic phenotype. Br J Cancer. 1998;77:270-276.
25. Sanz-Ortega J, Bryant B, Sanz-Esponera J, et al. LOH at the APC/MCC gene (5Q21) is frequent in early stages of non-small cell lung cancer. Pathol Res Pract. 1999;195:677-680.
26. Sasatomi E, Finkelstein SD, Woods JD, et al. Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage 11 non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res. 2002;62:2681-2689.
27. Sato S, Nakamura Y, Tsuchiya E. Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res. 1994; 54:5652-5655.
28. Shiseki M, Kohno T, Nishikawa R, et al. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res. 1994;54:5643-5648.
29. Takahashi T, Nau MM, Chiba I, et al. p53: a frequent target for genetic abnormalities in lung cancer. Science. 1989;246:491-494.
30. Thiberville L, Bourguignon J, Metayer J, et al. Frequency and prognostic evaluation of 3p21-22 allelic losses in non-small-cell lung cancer. Int J Cancer. 1995;64:371-377.
31. Travis WD, Colby TV, Corrin B, et al. World Health Organization. International Histological Classification of Tumors: Histological Typing of Lung and Pleural Tumors, 3rd ed. Berlin: Springer-Verlag, 1999.
32. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-532.
33. Yamasaki M, Takeshima Y, Fujii S, et al. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung. Pathol Int. 2000; 50:778-785.
34. Yamasaki M, Takeshima Y, Fujii S, et al. Correlation between morphological heterogeneity and genetic alteration within one tumor in adenocarcinomas of the lung. Pathol Int. 2000;50:891-896.
35. Yatabe Y, Konishi H, Mitsudomi T, et al. Topographical distributions of allelic loss in individual non-small-cell lung cancers. Am J Pathol. 2000; 157:985-993.
36. Yoshioka H, Takeuchi T, Matsuno Y, et al. Analysis of loss of heterozygosity in small adenocarcinomas of the lung. Jpn J Clin Oncol. 1998;28: 240-244.
37. Zajac-Kaye M. Myc oncogene: a key component in cell cycle regulation and its implication for lung cancer. Lung Cancer. 2001;34(suppl 2):S43-S46.